Marico pays ₹1,012 Cr to lift its PLIX stake to 84.09%, exercising rights disclosed since 2023

After market close on Monday, October 5, Marico told the exchanges it has acquired a further 24.09% of Satiya Nutraceuticals Private Limited — the company that owns the plant-based nutrition and personal care brand PLIX — for ₹1,012.03 crore in cash, taking its stake from 60% to 84.09% on a fully diluted basis. This was not a new deal surfacing: the filing itself points back to intimations of July 2023, November 2023, May 2025 and December 2025, under which Marico built the original 60% and held rights to acquire the remaining 40%. Monday's step-up is those rights being exercised.

The structure is worth reading precisely. The definitive agreements cover 38.18% — exactly the 24.09% just completed plus the 14.09% scheduled for July 2027 — against a right that originally extended to the remaining 40%, so the contracted position tops out at 98.18% on a fully diluted basis. The July 2027 consideration is not fixed: the filing gives a base of up to ₹592 crore — a cap on the base, not a floor — plus additional consideration tied to milestones under the agreements. So the final cost of the contracted 98.18% is not yet knowable from this disclosure — what is knowable is that ₹1,392.07 crore has bought 84.09%, and the last tranche carries a capped base with no disclosed overall ceiling.

Two pieces of arithmetic on the filing's own numbers frame the price. First, ₹1,012.03 crore for 24.09% implies a value of roughly ₹4,200 crore for Satiya Nutraceuticals as a whole — about 4.9 times its FY 2025–26 consolidated turnover of ₹864.31 crore. Second, subtracting this tranche from the ₹1,392.07 crore aggregate implies roughly ₹380 crore was paid for the first 60%, accumulated across the 2023–2025 intimations — a far lower price per percentage point than this tranche. Both figures are inferences from the disclosed totals, not numbers the filing states; the gap is at least consistent with how much larger the business has become since Marico first invested.

The filing describes Satiya Nutraceuticals — incorporated in February 2020, headquartered in Mumbai — as the owner of 'The Plant Fix – Plix', a plant-based nutrition and personal care brand, and says the investment has expanded Marico's addressable market in value-added foods and nutrition as well as personal care and wellness. The disclosed trajectory is steep: ₹155.32 crore of turnover in FY24, ₹432.84 crore in FY25, ₹864.31 crore in FY26 — a near-doubling in the latest year. For scale, that full-year figure compares with the ₹3,957 crore of consolidated revenue Marico reported in Q1 FY27 alone, so PLIX remains a small piece of the whole; the ₹1,012 crore tranche, meanwhile, works out to about 1% of Marico's ≈₹1,02,975 crore market capitalisation.

The filing reached the exchange at 20:14 IST on Monday, after the close, so the first session that could trade it was October 6 — and the stock moved +0.4%, from ₹790.00 to ₹793.10. Monday itself had opened to a different disclosure: the Q2 FY27 quarterly update, filed pre-open at 08:41 IST, which said domestic demand 'remained resilient' through the quarter even as the operating environment 'stayed volatile'; the stock closed that session up 1.1%. The bigger picture is a stock about 10.8% below its 52-week adjusted high of ₹889.10, set on July 30, and within sight of the ₹703.95 52-week low from October 2025 only in the sense that the drift since July has been steadily lower. A ₹1,012 crore outlay amounting to roughly 1% of market capitalisation, for a business the market already knew was on a path to full ownership, is the kind of event a muted reaction suggests was largely anticipated.